Growth of tumor‐infiltrating lymphocytes from human solid cancers: Summary of a 5‐year experience-Reference-Cited by-同舟云学术

Growth of tumor‐infiltrating lymphocytes from human solid cancers: Summary of a 5‐year experience

Published:1996-02-08 Issue:4 Volume:65 Page:413-421
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Intl Journal of Cancer

Author:

Yannelli John R.¹,Hyatt Cornelia¹,McConnell Susan¹,Hines Ken¹,Jacknin Laura¹,Parker Linda¹,Sanders Melinda¹,Rosenberg Steven A.¹

Affiliation:

1. National Cancer Institute, National Institutes of Health, Surgery Branch, Bethesda, MD 20892, USA

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/%28SICI%291097-0215%2819960208%2965%3A4%3C413%3A%3AAID-IJC3%3E3.0.CO%3B2-%23

Reference45 articles.

1. Lysis of Autologous Melanoma Cells by Tumor*Infiltrating Lymphocytes: Association With Clinical Response

2. Use of adoptive transfer of tumor‐Infiltrating lymphocytes alone or in combination with cisplatin containing chemotheray in patients with epithelial ovarian cancer;Aoki Y.;Cancer Res.,1991

3. Adoptive immunotherapy of advanced melanoma patients with interleukin-2 (IL-2) and tumor-infiltrating lymphocytes selected in vitro with low doses of IL-2

4. Interleukin 2 expanded tumor infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and anti‐Tumor activity;Belldegrun A.;Cancer Res.,1988

5. Interferon- α Primed Tumor-Infiltrating Lymphocytes Combined with Interleukin-2 and Interferon- α as Therapy for Metastatic Renal Cell Carcinoma

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TIL expansion with high dose IL-2 or low dose IL-2 with anti-CD3/anti-CD28 stimulation provides different quality of TIL-expanded T cell clones;Journal of Immunological Methods;2022-04

2. Recent Advances and Next Breakthrough in Immunotherapy for Cancer Treatment;Journal of Immunology Research;2022-03-18

3. Lymphocyte expansion in bioreactors: upgrading adoptive cell therapy;Journal of Biological Engineering;2021-04-13

4. CD137+ T-Cells: Protagonists of the Immunotherapy Revolution;Cancers;2021-01-26

5. Adoptive transfer of TILs plus anti-PD1 therapy: An alternative combination therapy for treating metastatic osteosarcoma;Journal of Bone Oncology;2020-12